发明名称 AMINOTHIAZOLE DERIVATIVE AS HUMAN STEAROYL-CoA DESATURASE INHIBITOR
摘要 <P>PROBLEM TO BE SOLVED: To provide a method of treating a stearoyl-CoA desaturase (SCD)-mediated disease or condition in a mammal. <P>SOLUTION: The method of treating the stearoyl-CoA desaturase (SCD)-mediated disease or condition in the mammal, preferably a human, comprises a step of administering to the mammal in need thereof a compound of formula (I). In the formula, V, W, R<SP POS="POST">1</SP>, R<SP POS="POST">2</SP>, R<SP POS="POST">3</SP>and R<SP POS="POST">4</SP>are defined in the specification. Pharmaceutical compositions comprising the compound of formula (I) are also disclosed. The disease or condition includes metabolic syndrome, Syndrome X, diabetes, insulin resistance, decreased glucose tolerance, non-insulin-dependent diabetes mellitus, Type II diabetes, Type I diabetes, diabetic complications, body weight disorders, weight loss, body mass index and leptin related diseases. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013100376(A) 申请公布日期 2013.05.23
申请号 JP20130042546 申请日期 2013.03.05
申请人 XENON PHARMACEUTICALS INC 发明人 FU JIANMIN;HOU DUANJIE;KAMBOJ RAJENDER;KODUMURU VISHNUMURTHY;POKROVSKAIA NATALIA;RAINA VANDNA;SUN SHAOYI;SVIRIDOV SERGUEI;ZHANG ZAIHUI
分类号 A61K31/4439;A61K31/426;A61K31/427;A61K31/433;A61K31/454;A61K31/5377;A61K31/55;A61K38/28;A61K45/00;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P7/02;A61P9/12;A61P17/00;A61P17/02;A61P17/06;A61P17/08;A61P19/06;A61P35/00;A61P43/00 主分类号 A61K31/4439
代理机构 代理人
主权项
地址